100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
79614-90-7Fluazinam Impurity 6
● In Stock
| Catalogue No.: | VE0027756 |
|---|---|
| CAS No.: | 79614-90-7 |
| Mol. Formula: | C13H4ClF7N4O4 |
| Mol. Weight: | 448.64 g/mol |
Additional information on CAS 79614-90-7
Parent drug
FluazinamIUPAC Name
3-chloro-N-(3-fluoro-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)pyridin-2-aminePharmacopeial Synonyms
N/ASynonyms
N/ASmiles
FC(C1=CN=C(NC2=C([N+]([O-])=O)C=C(C(F)(F)F)C(F)=C2[N+]([O-])=O)C(Cl)=C1)(F)FInChI
InChI=1S/C13H4ClF7N4O4/c14-6-1-4(12(16,17)18)3-22-11(6)23-9-7(24(26)27)2-5(13(19,20)21)8(15)10(9)25(28)29/h1-3H,(H,22,23)Description
Fluazinam Impurity 6 (CAS 79614-90-7) is a defined process-related impurity detected in technical fluazinam material, characterized by distinct HPLC retention behavior and diagnostic LC-MS/MS fragments indicative of partial aromatic substitution. It exhibits altered polarity and solubility versus the parent, affecting chromatographic resolution and extraction recovery. Routine control employs validated HPLC and GC-MS methods with established reporting, qualification, and acceptable limits to satisfy regulatory expectations. Formation is promoted under extended thermal or alkaline stress, so targeted synthetic optimization and purification strategies are recommended. Detailed impurity profiling and structural elucidation enable robust specification setting and analytical monitoring for consistent substance quality.Request a Quote
"*" indicates required fields
Other products related to Fluazinam impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
